Skip to content
10-Q

Quarterly Report

MEDICINOVA, INC. MNOV

0000950170-23-062079

← back to feed
Filed
Nov 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 7, 2023 49.05M sh
Cash And Equivalents Q3 2023 · Sep 30, 2023 $51.51M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $18.51M
Current Liabilities Q3 2023 · Sep 30, 2023 $2.8M
Current Liabilities Q3 2023 · Dec 31, 2022 $3.19M
Total Liabilities Q3 2023 · Sep 30, 2023 $3.47M
Total Liabilities Q3 2023 · Dec 31, 2022 $3.91M
Current Assets Q3 2023 · Sep 30, 2023 $53M
Current Assets Q3 2023 · Dec 31, 2022 $58.99M
Total Assets Q3 2023 · Sep 30, 2023 $68.14M
Total Assets Q3 2023 · Dec 31, 2022 $74.15M
Short Term Investments Q3 2023 · Dec 31, 2022 $39.98M
Shares Diluted Q3 2023 · Sep 30, 2022 49.05M sh
Shares Diluted Q3 2023 · Sep 30, 2022 49.05M sh
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$8.9M
Stockholders Equity Q3 2023 · Sep 30, 2022 $73.11M
Stockholders Equity Q3 2023 · Jun 30, 2022 $76.61M
Stockholders Equity Q3 2023 · Mar 31, 2022 $80.36M
Stockholders Equity Q3 2023 · Dec 31, 2021 $83.68M
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.07
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.23
Eps Basic Q3 2023 · Sep 30, 2022 −$0.07
Eps Basic Q3 2023 · Sep 30, 2022 −$0.23
Sga Expense Q3 2023 · Sep 30, 2022 $1.44M
Sga Expense Q3 2023 · Sep 30, 2022 $4.27M
Rd Expense Q3 2023 · Sep 30, 2022 $2.4M
Rd Expense Q3 2023 · Sep 30, 2022 $6.8M
Net Income Q3 2023 · Sep 30, 2022 −$3.65M
Net Income Q3 2023 · Sep 30, 2022 −$11.07M
Net Income Q3 2023 · Jun 30, 2022 −$4.03M
Net Income Q3 2023 · Mar 31, 2022 −$3.39M
Operating Income Q3 2023 · Sep 30, 2022 −$3.9M
Operating Income Q3 2023 · Sep 30, 2022 −$11.4M